Successful control of an outbreak of Klebsiella pneumoniae carbapenemase- producing K. pneumoniae at a long-term acute care hospital

Infection Control and Hospital Epidemiology

Volumn 31, Issue 4, 2010, Pages 341-347

  Munoz Price, L Silvia ^a,b,c,d   Hayden, Mary K ^e   Lolans, Karen ^e   Won, Sarah ^b,e   Calvert, Karen ^c   Lin, Michael ^e   Stemer, Alexander ^c,d   Weinstein, Robert A ^b,e  

^a UNIVERSITY OF MIAMI   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

^c Alverno Laboratories ^*

^d RUSH UNIVERSITY   (United States)

^e Jr Hospital of Cook County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; CHLORHEXIDINE GLUCONATE; KLEBSIELLA PNEUMONIAE CARBAPENEMASE; QUATERNARY AMMONIUM DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BATH; CLEANING; CLINICAL ARTICLE; EMERGENCY CARE; EPIDEMIC; GRAM NEGATIVE BACTERIUM; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; PATIENT CARE; POLYMERASE CHAIN REACTION; PREVALENCE; QUASI EXPERIMENTAL STUDY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CHLORHEXIDINE; CULTURE MEDIA; DISEASE OUTBREAKS; HOSPITALS; HUMANS; INFECTION CONTROL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LONG-TERM CARE; MICROBIAL SENSITIVITY TESTS; PATIENT ISOLATION; POPULATION SURVEILLANCE; PREVALENCE;

EID: 77949560265     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/651097     Document Type: Article

References (29)

1. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:1151-1161.
2. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob Agents Chemother 2007; 51:1553-1555.
3. Bratu S, Brooks S, Burney S, et al. Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin Infect Dis 2007;44:972-975.
4. Bratu S, Landman D, Alam M, Tolentino E, Quale J. Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob Agents Chemother 2005;49:776-778.
5. Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ, Whichard JM. Imipenem resistance in a Salmonella clinical strain due to plasmidmediated class A carbapenemase KPC-2. Antimicrob Agents Chemother 2003;47:1297-1300.
6. Cai JC, Zhou HW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid- mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008;52: 2014-2018.
7. Bratu S, Mooty M, Nichani S, et al. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 2005;49:3018-3020.
8. Chmelnitsky I, Navon-Venezia S, Strahilevitz J, Carmeli Y. Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates. Antimicrob Agents Chemother 2008;52:2962-2965.
9. Bratu S, Tolaney P, Karumudi U, et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 2005; 56:128-132.
10. Moland ES, Hanson ND, Herrera VL, et al. Plasmid-mediated, carbapenem- hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J Antimicrob Chemother 2003;51:711-714.
11. Bradford PA, Bratu S, Urban C, et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC- 2 and inhibitor-resistant TEM-30 β-lactamases in New York City. Clin Infect Dis 2004;39:55-60.
12. Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005;165:1430-1435.
13. Deshpande LM, Rhomberg PR, Sader HS, Jones RN. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005). Diagn Microbiol Infect Dis 2006;56:367-372.
14. Urban C, Bradford PA, Tuckman M, et al. Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase β-lactamases associated with long-term care facilities. Clin Infect Dis 2008;46:e127-e130.
15. Villegas MV, Lolans K, Correa A, et al. First detection of the plasmidmediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 2006;50: 2880-2882.
16. Cuzon G, Naas T, Demachy MC, Nordmann P. Plasmid-mediated carbapenem- hydrolyzing β-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 2008;52:796-797.
17. Monteiro J, Santos AF, Asensi MD, Peirano G, Gales AC. First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother 2009;53:333-334.
18. Naas T, Nordmann P, Vedel G, Poyart C. Plasmid-mediated carbapenemhydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 2005;49:4423-4424.
19. Won S, Munoz-Price LS, Lolans K, et al. Multi-facility emergence and rapid spread of KPC- Enterobacteriaceae in northwest Indiana (NWI) and Illinois (IL). In: Programs and Abstracts of the 19th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (San Diego). Arlington, VA: Society for Healthcare Epidemiology of America; 2009; Abstract 67.
20. Munoz-Price LS. Long-term acute care hospitals. Clin Infect Dis 2009;49: 438-443.
21. Gould CV, Rothenberg R, Steinberg JP. Antibiotic resistance in longterm acute care hospitals: the perfect storm. Infect Control Hosp Epidemiol 2006;27:920-925.
22. Anderson KF, Lonsway DR, Rasheed JK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007;45:2723-2725.
23. Matushek MG, Bonten MJ, Hayden MK. Rapid preparation of bacterial DNA for pulsed-field gel electrophoresis. J Clin Microbiol 1996;34:2598- 2600.
24. Tenover FC, Arbeit RD, Goering R, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
25. Munoz-Price LS, Hota B, Stermer A, Weinstein RA. Prevention of bloodstream infections using daily chlorhexidine baths at a long-term acute care hospital. Infect Control Hosp Epidemiol 2009;30:1031-1035.
26. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007;35(10 Suppl 2):S65-S164.
27. Guidance for control of infections with carbapenem-resistant or carbapenemase- producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256-260.
28. Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, Weinstein RA. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006;166:306-312.
29. Larson EL, Cimiotti JP, Haas J, et al. Gram-negative bacilli associated with catheter-associated and non-catheter-associated bloodstream infections and hand carriage by healthcare workers in neonatal intensive care units. Pediatr Crit Care Med 2005;6:457-461.